European Life Technologies
Where science, technology, and expertise meet
Our goal is to improve the chances of recovery for cancer patients worldwide as a globally leading player in liquid biopsy, with the help of the most modern genetic technologies, cloud-based IT solutions, and decades of molecular biology experience
Scroll
Expertise, innovation, and commitment
Innovative ecosystem
From sampling to the relevant report!
The genetic pattern of tumors is unique for every patient, which is why we have created a system that reveals this uniqueness quickly, reliably, and in a clinically interpretable (relevant) manner. Building on the technological background of Enterprise Group Technologies, we developed the Enterprise Cloud Platform™ and the genoAId™ bioinformatic platforms, which transform complex genomic data into accurate diagnostic information.
In 2023, we transformed into a public limited company and introduced under the brand name genosmartDX (GSDX) the service platform that manages the entire diagnostic process — from sampling to medical report — in a unified digital ecosystem. Thus, our solutions have moved beyond the laboratory environment and have become directly usable, value-creating decision-support tools for patients, physicians, and institutional partners alike.
